Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.
Koh
Liang-Piu
LP
Kanagalingam
Devendra
D
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D016898:Interferon-alpha / Q000008:administration & dosage*; D007937:Leukapheresis; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D050498:Live Birth; D010879:Piperazines / Q000008:administration & dosage*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy; D011252:Pregnancy Complications, Neoplastic / Q000628:therapy*; D011743:Pyrimidines / Q000008:administration & dosage*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D001549:Benzamides; D016898:Interferon-alpha; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate